がん治療における世界の新規ドラッグデリバリーシステムの市場規模は、2023年に167億9000万ドルと評価され、2024年から2030年にかけて7.5%のCAGRで成長すると予測されます。標的療法、精密医療、個別化治療アプローチの出現、および低侵襲手術の採用の増加が、世界市場の成長を推進しています。さらに、新薬開発の需要が、従来の治療法に関連する副作用を最小限に抑えながら患者の転帰を向上させる効果的な治療オプションの必要性によって推進されています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Novel Drug Delivery Systems In Cancer Therapy Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Novel Drug Delivery Systems In Cancer Therapy Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Novel Drug Delivery Systems In Cancer Therapy Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Novel Drug Delivery Systems In Cancer Therapy Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Nanoparticles
4.3.1. Nanoparticles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. Liposomes
4.3.2.1. Liposomes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. Polymers
4.3.3.1. Polymers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.4. Micelles
4.3.4.1. Micelles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.5. Other Nanoparticles
4.3.5.1. Other Nanoparticles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Embolization Particles
4.4.1. Embolization Particles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. PVA Particles
4.4.2.1. PVA Particles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Drug Eluting Beads
4.4.3.1. Drug Eluting Beads Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Liquid Emboli
4.4.4.1. Liquid Emboli Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.5. Other Embolization Particles
4.4.5.1. Other Embolization Particles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Novel Drug Delivery Systems In Cancer Therapy Market: Regional Estimates & Trend Analysis
5.1. Novel Drug Delivery Systems In Cancer Therapy Market Share, By Region, 2023 & 2030 (USD Million)
5.2. North America
5.2.1. North America Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Canada Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.4. Mexico
5.2.4.1. Mexico Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. UK
5.3.2.1. UK Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Germany Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. France
5.3.4.1. France Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Italy Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Spain Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. Denmark
5.3.7.1. Denmark Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.8. Sweden
5.3.8.1. Sweden Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.9. Norway
5.3.9.1. Norway Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Japan
5.4.2.1. Japan Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. China
5.4.3.1. China Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. India
5.4.4.1. India Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. Australia
5.4.5.1. Australia Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.6. South Korea
5.4.6.1. South Korea Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.7. Thailand
5.4.7.1. Thailand Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Brazil Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Argentina
5.5.3.1. Argentina Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Middle East and Africa
5.6.1. Middle East and Africa Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.2. South Africa
5.6.2.1. South Africa Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.3. Saudi Arabia
5.6.3.1. Saudi Arabia Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.4. UAE
5.6.4.1. UAE Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.5. Kuwait
5.6.5.1. Kuwait Novel Drug Delivery Systems In Cancer Therapy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Heat Map Analysis
6.4. Company Profiles
6.4.1. Bristol-Myers Squibb Company (Celgene Corporation)
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Recent Developments/Strategic Initiatives
6.4.2. Teva Pharmaceutical Industries Ltd
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Recent Developments/Strategic Initiatives
6.4.3. Johnson & Johnson Services, Inc.
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Recent Developments/Strategic Initiatives
6.4.4. Galen Limited
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Recent Developments/Strategic Initiatives
6.4.5. Shire (Takeda Pharmaceutical Company Limited)
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Recent Developments/Strategic Initiatives
6.4.6. Samyang Holdings Corporation
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Recent Developments/Strategic Initiatives
6.4.7. Merrimack Pharmaceuticals
6.4.7.1. Participant’s Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Recent Developments/Strategic Initiatives
6.4.8. Spectrum Pharmaceuticals, Inc.
6.4.8.1. Participant’s Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Recent Developments/Strategic Initiatives
